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The concept and characteristics ofdifferent types ofhematopoietic cells have been described.
Hematopoietic stem cells are currently considered to exist in a variety of populations with
different degrees of commitment towards a particular cell line. By a combination of animal
studies and studies with hematopoietic disorders, the concept of dividing hematopoietic stem
cells into uncommitted and committed types has emerged in the past several years. Uncommit-
ted stem cells are capable of differentiation, under the proper stimulus, into either of the cell
lines of the hematopoietic system. These cells form a resting population of cells with a low
mitoitic rate and a long resting (G,)) phase. The committed stem cells are partially differenti-
ated and mature only into one type of cell. The committed stem cell population is relatively
more active than the population of uncommitted stem cells.
A variety of assays both in vivo and in vitro are currently available for the study ofdifferent
hematopoietic stem cells. These assays are semiquantitative. The number ofcolonies ofmature
cells which develop after the infusion or plating of a population of cells containing the stem
cells is proportional to the total number of cells infused.
A variety of toxic as well as biological substances have been assayed in these systems and a
quantitative depression of the number of colonies produced has been noted by a variety of
workers. The degree ofdepression in the number ofcolonies varies with the agent in use and the
type of assay employed. These studies have demonstrated that toxicity of chemicals on the
hematopoietic stem cells can be studied with these in vitro and animal studies to give an
assessment of their potential toxicity in the intact organism.
The recent development of the Dexter two-layer liquid culture system has provided a new
impetus to the research on the uncommitted stem cell in a variety of organisms.
Most cell systems in mammals are comprised of
differentiated cells with little or no self renewal.
However, the gastrointestinal mucosa, skin, and
the hematopoietic system have a large turnover
and self renewal capability. This self renewal de-
pends on a cell.population referred to as stem cells.
These cells are characterized bythe dual capacity of
selfrenewal and ofdifferentiation into more mature
types ofcells. Stem cells have been studied in great
detail in the hematopoietic system largely due to
the easy accessability of the cells (1).
Hematopoietic stem cells exist in different "popu-
lations" which are based on the degree of commit-
ment to one or other cell type. Through a large
amount ofin vivo and in vitro work in humans and
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animals, a number of biological features of these
cells have been defined. It has been shown that
there exists in the hematopoietic system a popula-
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FIGURE 1. Schematic representation ofthe pathways followed
by a stem cell. Note the need for a stimulus for differentia-
tion and the high priority for self renewal.
51tion ofuncommitted or pluripotent stem cells capa-
ble ofgiving rise to another population ofstem cells
committed to different cell lines. Committed stem
cells for the granulocytic series, the erythroid
series, lymphocytes, and megakaryocytes have been
defined. In this paper, we will briefly review the
current knowledge of the characteristics of the
hematopoietic stem cells, the assays employed for
their study, and the potential use ofsuch assays for
determining myelotoxicity.
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stimulating factor (CSF) or colony-stimulating ac-
tivity (CSA) (3).
Studies ofthe pluripotent stem cell are based on
in vitro and in vivo techniques which measure the
differentiated progeny ofthe stem cell. The kinetics
of these stem cells have been studied primarily by
disturbing their equilibrium by inducing changes in
the progeny. For example, the induction of anemia
leads to the mobilization of stem cells towards
increased production of red cells while polycythe-
mia suppresses erythropoiesis. These phenomenon
can be easily quantitated and studied. Tritiated
thymidine suicide experiments have shown that
most pluripotent stem cells are in the resting or Go,
phase. Thus, a large proportion of stem cells are
normally not undergoing DNA synthesis. At the
same time, it has been shown that after pertubation
of stem cells, the DNA synthetic rate increases in
proportion to the need for mature cells in the
peripheral blood.
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FIGURE 2. Schematic representation ofthe interrelationship of
the different stem cell populations and the morphologically
recognizable precursors of blood cells.
Characteristics of Stem Cells
At the present time, stem cells are recognized by
their functional characteristics and have not been
identified morphologically. The concept ofthe stem
cell is that of a cell population which has the
capability ofdifferentiating, underappropriate stim-
uli, into more mature cells and at the same time
have a potential for self renewal. The first feature
provides the immediate needs in the peripheral
blood and the self renewal capacity provides a
reservoir of precursor cells for long-term needs. It
may be mentioned at this point that the self-
renewal capacity is less striking in the committed
stem cells as compared to the uncommitted stem
cells.
The factors controlling egress ofpluripotent stem
cells into the committed compartments are poorly
understood. The stimulus for differentiation of
committed stem cells is humoral in nature. The best
characterized ofthe humoral factors is erythropoietin
(2). A factor with activity on committed granulo-
cyte stem cells has also been characterized and
studied in detail. This is referred to as colony-
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Types of Hematopoietic Stem Cells
Since the 1920's, based on the work ofMaximow,
the concept of hematopoietic stem cells as precur-
sors for erythrocytes, different types ofleukocytes,
and platelets has been accepted. There has, howev-
er, been a considerable amount of debate as to
whether there was a single pluripotent stem cell for
all cell types or different types of unipotent stem
cells for each cell line. More recent evidence has
shown that there exists in the hematopoietic sys-
tem (in all species studied) a pluripotent stem cell
and also unipotent stem cells committed to differen-
tiation towards each of the cell lines. These stem
cells have been identified by the nature of their
progeny and by the response to different types of
stimuli. Kinetic differences between uncommitted
pluripotent stem cells and the stem cells committed
to erythropoiesis and granulopoiesis have also been
shown.
Uncommitted Pluripotent Stem
Cells
This is a resting population of cells which are
capable ofgiving rise to cells ofdifferent lineages in
the hematopoietic system. Granulocytic, erythroid,
and megakaryocytic cell lines are derived from
these cells. Lymphocytes and fibroblasts in the
marrow may also be derived from an earlier form of
the pluripotent stem cells.
This cell population has been identified by a
number of techniques especially in mice. The Till
and McCulloch technique (4) (described in detail
Environmental Health Perspectivesbelow) has demonstrated cells capable ofproducing
granulocytic, erythroid, megakaryocytic, and mixed
colonies when syngeneic bone marrow cells are
given intravenously to lethally irradiated mice. By
manipulation of the status of the recipient or the
donor mouse, it has been possible to show that this
stem cell is responsive to humoral stimuli (5).
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FIGURE 3. Outline of the Till and McCulloch assay for
pluripotent stem cells in mice (CFU-S).
Evidence for a pluripotent stem cell in the human
comes from studies of diseases like chronic myeloid
leukemia and polycythemia vera. Clinical and
hematological observations, chromosomal analysis
(6), and analysis of glucose-6-phosphate dehydro-
genase isomers (7) have shown a clonal abnormality
in both these diseases. It has also been demon-
strated that a clonal abnormality is present in the
granulocytic, erythroid, and megakaryocytic cell
lines. Fibroblasts and lymphocytes are free of this
clonal abnormality.
The most definitive assay and method of demon-
stration of the pluripotent stem cell is the Till and
McCulloch technique. Since this leads to colony
formation in the spleen, this cell is commonly
referred to as the colony forming unit in spleen
(CFU-S) and is the best model for pluripotent stem
cells. CFU-S have been demonstrated to be present
in the bone marrow, spleen, fetal liver, and also
circulating in peripheral blood. Further, the colo-
nies formed in the recipient mice also contain
CFU-S capable of forming secondary colonies in a
second recipient.
Morphological identification of CFU-S is not
possible at the present time. A number of cell
separation techniques suggest that CFU-S frac-
tionate with mononuclear cells with morphology
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similartolymphocytes/monocytes (8). Transplantation
experiments have shown that CFU-S are capable of
repopulating the bone marrow and of restoring
normal hematopoiesis after it has been dlestroyed
by radiation, drugs, or other mechanisms.
Assay of CFU-S
Spleen Colony. The most commonly employed
assay for multipotential stem cells is the technique
of Till and McCulloch (4). This assay was first
described in 1961 and has become the most stan-
dard assay for the multipotential stem cell. In fact,
the cell assayed in this system, CFU-S, is consid-
ered to be, for practical purposes, synonymous for
the multipotential stem cell.
Syngeneic mice are employed in this assay. One
set ofmice is given lethal radiation, approximately
700 rad, to produce destruction of all endogenous
hematopoietic tissue in the bone marrow and spleen.
Bone marrow cells from unradiated syngeneic mice
are given intravenously. After 8-10 days, the recip-
ient mice are sacrificed at which time macroscopic
nodules ofhematopoietic cells are seen in the spleen
and the bone marrow. These consist of erythroid,
granulocytic, megakaryocytic, and mixed colonies.
It is the formation of these colonies in the spleen
that gives the name colony forming unit-spleen for
the cells assayed by this system.
The number ofcolonies formed is proportional to
the number of bone marrow cells infused. This
assay can be used to study, in a quantitative
manner, the kinetics of CFU-S. At the same time,
humoral and other influences on the CFU-S can be
studied. For example, if the recipient mice are
rendered anemic, a larger number of erythroid
colonies are seen as compared to the other types.
On the other hand, if the recipient mice are made
polycythemic very few erythroid colonies are seen.
Erythroid differentiation can be induced by exoge-
nous erythropoietin. The self-renewal potential of
the CFU-S can also be demonstrated in this assay.
Ifcoloniesfromthespleenare dissected, resuspended,
and infused into a second set ofradiated syngeneic
hosts, further colony formation is noted, demon-
strating thereby the presence of multipotential
stem cells in the colonies which showed differentia-
tion into one or more cell lines. Not directly a part
of the assay but of biological significance is the
distribution ofcolonies in different parts ofthe bone
marrow and spleen; erythroid colonies are more
often seen on the surface while granulocytic and
megakaryocytic colonies are usually deeper.
Endogenous CFU-S can also be demonstrated by
modification of this technique. If mice are given
lethal radiation with shielding of one leg, hema-
53topoietic recovery takes place and also colonies are
seen in the spleen after 10-15 days. These colonies
have essentially the same characteristics as those
obtained from syngeneic mouse bone marrow. These
latter experiments demonstrate the capability of
stem cells to circulate in the blood and reseed the
bone marrow and spleen.
Dexter Culture. This is a relatively new tech-
nique (9) for culture ofhematopoietic cells which as
yet has not been fully exploited. However, it offers
a great potential for study of hematopoietic stem
cells, both the uncommitted and the committed.
In this system, bone marrow cells are grown in
tissue culture flasks. The culture flasks are incu-
bated in an atmosphere of5% CO2 in air at 37°C for
3 weeks. During this period, the medium and
nonadherent cells are removed twice weekly and
replaced with fresh medium. After approximately 3
weeks, an adherent layer is formed in the tissue
culture flask. The adherent layer consists of
phagocytic mononuclear cells, "epitheloid" cells,
and giant fat containing cells. Once a monolayer is
formed, a second batch of bone marrow cells is
added to this culture. The environment provided by
the adherent cell layer allows the proliferation of
stem cells in the culture system. Both pluripotent
stem cells (CFU-S) and granulocytic committed
stem cells [colony-forming unit in culture (CFU-C)]
proliferate in the nonadherent layer in the second-
ary culture. (CFU-C are described in further detail
below.) The Dexterculture is a means ofamplification
of CFU-C and CFU-S and thereby provides an
easily accessible source of these stem cell popula-
tions.
To date, the potentials ofthe Dexter culture have
not been fully utilized but it can be seen that this
culture system would allow the study of a large
number ofmodifications for an understanding ofthe
basic biology of stem cells and also a means of
studying changes in them by drugs and other
modifiers.
Use of CFU-S for Toxicity Studies
The CFU-S assay for stem cells has been used for
study of drug/chemical toxicity by a number of
workers. Fostad and Pihl (10) studied ricin and
abrin, two toxic plant lectins with cancerostatic
properties, in the CFU-S system. They also studied
adriamycin and 5-fluorouracil, two standard cancer
chemotherapeutic agents, in the same system. The
drugs were given to donor mice in an escalating
dose schedule. Three days later their bone marrow
cells were infused into radiated recipients. The
number of CFU-S obtained from the femurs of
treated mice decreased progressively as the dose of
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FIGURE 4. Outline ofthe Dexter assay for CFU-S and CFU-C
in vitro.
drug increased over a three-fold range. The higher
dose was near the LD50.
Uyeki et al. (11) used CFU-S and CFU-C assays
to study the effect of benzene inhalation on mice.
They found bone marrows from mice exposed to
benzene produced 7.5 ± 0.3 colonies/105 cells as
opposed to 18.7 ± 0.7 colonies in control animals.
Thus, the pluripotent stem cell, as measured by the
CFU-S, is responsive to the effect of known
myelotoxic agentsand adoserelationshipissuggested
by the available data. Data obtained by using the
Dexter culture for study oftoxins are not available
at the present time.
Committed Unipotent Stem Cells
Granulocyte Committed Stem Cells
The granulocytes include neutrophils (polymor-
phonuclearleukocytes-PMN), eosinophils, basophils,
Environmental Health Perspectivesand possibly the monocytes. Neutrophil kinetics
have been studied in some detail and a fairly clear
picture of the later stages of their kinetics has
emerged (12, 13). Granulocytes are derived from a
committed stem cell commonly referred to as the
colony forming unit in culture (CFU-C). The matu-
ration of CFU-C depends on a stimulus commonly
referred to as colony stimulating factor (CSF) (3).
CSF is heterogeneous and, at the present time, its
chemistry is poorly worked out. However, a num-
ber of subtypes of CSF have been recognized with
activity of different types (3).
A morphologically identifiable population of di-
viding and maturing cells is derived from the
CFU-C. This proliferates in the bone marrow and
leads to amplification of the granulocyte precur-
sors. From the mitotic compartment (myeloblasts,
promyelocytes, and myelocytes), a pure maturation
compartment of cells is derived (metamyelocytes
and bands) which is present only in the bone
marrow. Finally, mature granulocytes emerge from
the bone marrow into the blood. The total time
period for the maturation of myeloblast to neutro-
phil is approximately 10 days. There is a large
reserve of mature granulocytes in the bone mar-
row.
In the peripheral blood, neutrophils are present
in two interchangeable compartments, the circulat-
ing granulocyte pool (CGP) and the marginated
granulocyte pool (MGP). The two together consti-
tute the total blood granulocyte pool (TBGP) (13).
The circulating granulocyte pool is sampled by the
usual techniques of venipuncture while the
marginated pool cannot be sampled by this tech-
nique. Demargination occurs under the influence of
a number of factors, particularly the release of
epinephrine.
The egress ofgranulocytes from peripheral blood
into the tissues is exponential, and the half life of
granulocytes in circulation is 6-8 hr. These data are
of importance because the reserve of granulocytes
in the bone marrow and the peripheral blood MGP
may produce a discrepancy between the degree of
granulopoiesis and the total number of granulo-
cytes sampled from blood. This, combined with the
time lag in the maturation ofmyeloblasts to granu-
locytes and the various factors responsible for the
release of granulocytes from the bone marrow,
makes the quantitation ofgranulopoiesis somewhat
difficult. Assessment ofgranulopoiesis from changes
in peripheral blood is not accurate and is better
studied in the context of the changes in the early
phase in the bone marrow rather than from the
changes in peripheral blood.
CFU-C Assay. The CFU-C and its assay was
first described in 1965 for mice (14, 15) and for
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humans in 1970 (16). In this in vitro assay, bone
marrow cells are plated in semisolid agar with
nutrients and the stimulus (CSF). The source of
CSF can be from urine, peripheral blood cells (16),
or from placental conditioned medium(3). After
7-14 days of incubation in an atmosphere of full
humidification with 7.5% CO2 in air at 37°C, dis-
crete colonies of mature granulocytes are seen.
These colonies have 50 to 500 cells and also smaller
clusters of cells are seen under certain circum-
stances. These colonies consist of mature granulo-
cytes and, in some cases, macrophages. It has been
demonstrated that these colonies are clonal in
nature (17). There is a semiquantitative relation-
ship between the number of bone marrow cells
plated and the amount of CSF provided to the
number of colonies formed (12). By keeping a
constant number of bone marrow cells in the
system, CSF can be assayed, and by maintaining a
constantamountofstimulus, CFU-Ccanbeassayed.
At the same time, ifboth CSF and CFU-C are kept
constant, the addition ofother stimuli or inhibitors
can be studied and the changes produced can be
measured.
Use of CFU-C for Toxicity Studies. Uyeki et
al. (11) used the CFU-C assay to study the effects
of benzene inhalation on hematopoiesis in mice.
Mice were exposed to benzene vapors (4680 ppm)
for 8 hr. The mice were sacrificed on days 1, 4, and
7. Bone marrow was taken from the exposed mice
and plated with colony stimulating factor. The
results were expressed as percentage of control
using the number of colonies formed from 105 bone
marrow cells and also by the total number of
CFU-C colonies from one femur. A significant
decrease in CFU-C was noted from femurs obtained
one day after benzene inhalation. On day 1, the
value was approximately 39% of control. By the
fourth day, this had increased to 66% and by day 7,
it was up to 77%. This suggests the toxicity of
benzene on CFU-C is reversible with time.
Schein et al. have studied the effect of a number
ofdrugs on the CFU-C (18, 19). They have shown a
dose related inhibition of CFU-C from the bone
marrow of mice treated with these drugs.
Interferons are glycoproteins produced by a
variety of vertebrate cells in response to viral
infections. Apart from the antiviral effect, they
have been shown to have a number of effects on
cellular functions (20, 21). Hull et al. (22) studied
the effect of human and mouse interferons on
CFU-C and CFU-E. They noted a consistent
inhibitory effect of interferon on growth of both
types ofcommitted stem cells in humans and in the
mouse system. There was a dose-related response
noted. Further, they noted adifferential effect with
55different types ofinterferons and a difference in the
effect on CFU-C and erythroid committed stem
cells, (CFU-E). Human fibroblast and human leu-
kocyteinterferon inhibited thegrowthofthe CFU-E
equally. However, with the CFU-C system, human
leukocyte interferon was much more potent and
produced a 50% inhibition of colony formation at a
concentration approximately 1000-fold less than
that required with human fibroblast interferon.
These data point to the specificity of the action of
interferon and, more importantly, point to the
quantifiable nature ofthis assay for different types
of inhibitory activity.
Nissen et al. (23) also reported the response of
human CFU-C to interferon. They also found a
dose related inhibition of CFU-C when cultures
were grown in the presence of interferon.
In view of the recent interest in interferons,
particularly as anticancer agents, it may be worth-
while to mention some aspects ofthe relationship of
interferon to CSF. Both CSF and interferon are
glycoproteins with similar electrophoretic ability.
Further, the production of both is stimulated by
synthetic polynucleotides, particularly Poly I-Poly
C. The biological significance of these observations
is not clear but raises the speculation that interfer-
ons and CSF both maybe physiologically important
substances related to cell regulation.
Erythroid Committed Stem Cells
The kinetics of red blood cells is much simpler
than the kinetics of granulocytes. Erythroblasts
which develop from erythroid committed stem cells
differentiate and mature in the bone marrow with a
progressive decrease in total cell size and nuclear
size. There is also a progressive increase in the
hemoglobin content ofthe cells. By the stage ofthe
reticulocytes, the nuclear material is extruded and
the cell is completely hemoglobinized. The precur-
sor cell, up to the stage of reticulocyte, matures
entirely within the bone marrow. The reticulocytes
spend approximately 24 hr in the bone marrow and
subsequently circulate as reticulocytes in periph-
eral blood for another 24 hr. The reticulocytes then
mature into adult red cells which have no nuclear
material and are largely concerned with transport
of oxygen through their hemoglobin content. Red
cells spend approximately 120 days in circulation,
at which time following a process of senescence,
they are destroyed by the cells of the reticulo-
endothelial system. Unlike granulocytes, red cells
spend their entire life span within the vascular
compartment and their loss is age dependent and,
therefore, not exponential. In humans, at least,
there is minimal amount of storage of red cells in
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the vascular compartment or the bone marrow. For
these reasons, the assessment of erythropoiesis on
the basis of changes in the peripheral blood is
relatively easy.
The erythroid committed stem cells have been
studied in some details. In vivo and in vitro studies
have shed a considerable amount of light on the
nature of these stem cells. In vivo, it was first
demonstrated in the 1950's that the production of
polycythemia in radiated mice led to a lack of
erythroid differentiation which could be reversed
by the addition of erythroipoietin (24). Thus, the
concept ofthe erythropoietin responsive cells (ERC)
was developed. The ERC were further studied in
vitro. Studies ofthe kinetics ofthis cell and also its
responsiveness to different stimuli have demon-
strated the existence of at least two populations in
ERC. These have been classified into the burst-
forming unit-erythroid (BFU-E) and the colony-
formingunit-erythroid (CFU-E). The burst-forming
unit is considered to be the more primitive cell; it
responds to higher concentrations oferythropoietin,
takes a longer time in culture, and produces rela-
tively larger colonies. The CFU-E, on the other
hand, is derived from the BFU-E, it requires lower
concentrations of erythropoietin, takes only 3-4
days of culture and produces small clusters of
erythroid cells (25-27). More recent data have
suggested that the activity of the erythropoietin
containing preparations may have a separate stimu-
lus which acts on more primitive cells and this
activity has been referred to as burst promoting
activity (BPA) (28).
Assay of Red Cell Precursors. Both liquid
culture and semisolid culture systems have been
employed for assay of red cell precursors. Howev-
er, the liquid culture system mainly studies the
hemoglobin synthesis by erythroblasts which do
not have stem cell characteristics and are relatively
late forms oferythroid precursors. This system will
not be discussed in any detail though it has been
described elsewhere (29).
The semisolid culture system has two variants,
both ofwhich provide the same type ofinformation
and are usable for the study of stem cells, the
various stimuli which affect the stem cells, and also
to study the effect of exogenous agents. Like the
assay ofCFU-C, these systems employ a source of
stem cells (usually bone marrow), provide adequate
amounts of nutrients, a method of stabilizing the
cells and a source ofstimulus. Incubation is carried
out in an atmosphere of 5% CO2 in air with full
humidification at 370C.
The plasma clot culture system first described by
Axelrad and others has been used more commonly
(25). However, the technique employing methyl-
Environmental Health Perspectivescellulose as the stabilizing agent is also useful. The
methycellulose system has been described by Iscove
and Sieber (26). Both these cultures are quantita-
tive in their response to the various stimuli and also
to the number of cells put into the culture. The
Axelrad culture has been employed in a number of
situations for study of toxic exogenous iiaterials.
Use ofCFU-E for Toxicity Studies. Hull et al.
(22), as described earlier, employed CFU-C cul-
tures to study the effect of interferon both in the
human and the mouse system. In both systems,
they demonstrated a quantitative relationship of
the inhibition of colony formation by increasing
concentrations of interferon. Approximately 50%
reduction was noted at a concentration of 103
interferon units/ml of culture. The differential ef-
fect noted with leukocyte and fibroblast interferon
on CFU-C was not seen with CFU-E.
Wallner et al. studied the effect of serum from
patients with chronic renal failure on the growth of
CFU-E. They found a quantitative relationship in
the depression of colony fromation by the addition
of serum from patients with chronic renal failure
but not from serum of normal controls (30).
Megakaryocyte Committed Stem Cells
At the present time, because of technical rea-
sons, the feasibility of studies on megakaryocyte
committed stem cells is limited. Even though
megakaryocyte committed stem cells have been
demonstrated by some workers, the growth ofsuch
colonies is possible under only very exacting condi-
tions and their potential for use for the study of
toxicity on the stem cell is relatively limited (31).
Conclusion
The hematopoietic stem cells provide a sensitive
and relatively simple system for assessment of
toxicity of potential environmental hazards. At
different times in different assays, the effect of
industrial chemicals, chemotherapeutic drugs, and
biological materials has been demonstrated using
assays of hematopoietic stem cells. The assays, by
and large, have been demonstrated to be quantita-
tive in nature and have a reasonable degree of
specificity for the stem cells.
Theconditionsrequiredforculture ofhematopoietic
stem cells are fairly exacting. However, at the
same time, they allow a fair amount offlexibility in
the amount ofstimulus provided and the number of
bone marrow cells put into a system. This flexibility
should allow these techniques to be used for the
study of a variety of toxic materials in these
systems.
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